Trials / Completed
CompletedNCT03460756
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
A Phase 2, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Oral Administration of Ganaxolone in Women With Postpartum Depression
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Marinus Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
A clinical study to evaluate safety, tolerability and efficacy of oral administration of ganaxolone in women with postpartum depression
Conditions
- Depressive Disorder
- Depression
- Depression, Postpartum
- Behavioral Symptoms
- Mood Disorders
- Mental Disorder
- Pregnancy Complications
- Postpartum Blues
- PPD
- Postpartum Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ganaxolone | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2017-12-28
- Primary completion
- 2019-07-05
- Completion
- 2019-07-05
- First posted
- 2018-03-09
- Last updated
- 2023-08-18
- Results posted
- 2023-01-30
Locations
33 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03460756. Inclusion in this directory is not an endorsement.